Table 8 Multiple linear regression analysis with backward elimination method of the factors affecting estimated GFR in renal transplant recipients
Variables | Unstandardized B (95% CI) n = 75 | Standardized beta | p |  |
|---|---|---|---|---|
Age | −0.002 (− 0.6–0.5) | −0.001 | 0.99 | excluded |
Days post-transplantation | 0.0 (−0.004–0.004) | 0 | 1.000 | excluded |
Living vs deceased donor | 15 (0.1–29) | 0.22 | 0.049 |  |
Cold ischemia time (hours) | 0.15 (−2–2) | 0.03 | 0.87 | excluded |
HLA-mismatches (HLA-A, B, DR) > 3 | 0.8 (−13–14) | 0.014 | 0.9 | excluded |
Delayed graft function | −2 (− 26–22) | 0.02 | 0.88 | excluded |
Induction (Basiliximab vs. ATG) | 13 (−1–26) | 0.2 | 0.07 | excluded |
Previous rejections | −5 (−19–9) | −0.1 | 0.46 | excluded |
Daily steroid dose (mg) | −0.4 (−1–0.5) | −0.1 | 0.40 | excluded |
Protein-creatinine-ratio (g/mol) | −0.02 (− 0.1–0.03) | −0.1 | 0.31 | excluded |
Previous CMV | 3 (− 11–18) | 0.05 | 0.68 | excluded |
Previous BKVN | −19 (−49–11) | −0.15 | 0.21 | excluded |
CRP (mg/l) | −0.1 (− 0.2–0.02) | −0.2 | 0.053 | excluded |
CD19 + CD25+ Bregs/μl | 11 (1.5–20) | 0.26 | 0.02 |  |
Tregs/μl | −0.4 (−1.5–0.4) | −0.1 | 0.34 | excluded |